Individualized Choices in Antiretroviral Therapy: Present and Future

Here’s why patients need to be placed front and center when choosing antiretroviral therapy.

Silvia Petretti Released: October 22, 2021

Here’s why I think the 3 most essential aspects when switching ART are treatment history, genetic barrier to resistance, and hearing what your patient is telling you.

Chloe Orkin, MBChB, FRCP, MD Released: November 24, 2021

Here are my thoughts on how the emergence of long-acting ART reflects the continued evolution of HIV treatment to better meet the broad needs of our patients and what ongoing research efforts may bring about for future long-acting ART options.

Jean-Michel Molina, MD, PhD Released: November 30, 2021

How soon should ART be initiated in patients who present with opportunistic infections, and what is the best regimen? In this commentary, I share my approach to starting ART in patients with advanced HIV and opportunistic infections.

Cristina Mussini, MD Released: December 13, 2021